Učitavanje...
Programmed Death Ligand 1 Expression and Tumor Infiltrating Lymphocytes in Neurofibromatosis Type 1 and 2 Associated Tumors
INTRODUCTION: Immune checkpoint inhibitors targeting programmed cell death 1 (PD-1) or its ligand (PD-L1) have been shown to be effective in treating patients with a variety of cancers. Biomarker studies have found positive associations between clinical response rates and PD-L1 expression on tumor c...
Spremljeno u:
| Izdano u: | J Neurooncol |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5930071/ https://ncbi.nlm.nih.gov/pubmed/29427150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-018-2788-6 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|